Escherichia Coli Bacteremia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Escherichia Coli Bacteremia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06080698

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early…

United States1,030 participantsStarted 2024-02-22

Treatment: Intravenous Antibiotics, Oral Antibiotics

All recent trials (8 shown)

Not Yet RecruitingPhase 2

NCT07318584

Cefotetan Therapy for Escherichia Coli Infections

This pilot study will compare clinical outcomes among patients treated with cefotetan versus standard of care antibiotics for bacteremia or genitourinary infect…

United States84 participantsStarted 2026-03

Treatment: Cefotetan, Carbapenems

TerminatedNot Applicable

NCT05613322

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

The aim of this study is to assess the sensitivity, specificity, and accuracy of the Resistell Phenotech device in testing antibiotic susceptibility of Gram-neg…

Austria, Spain, Switzerland246 participantsStarted 2023-01-18

Treatment: Resistell Phenotech

Escherichia Coli Bacteremia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

All recent trials (8 shown)

Cefotetan Therapy for Escherichia Coli Infections

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

All recent trials (8 shown)

Cefotetan Therapy for Escherichia Coli Infections

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

Switch to Oral Antibiotics in Gram-negative Bacteremia

The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenot…

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Granzyme A in Patients With E. Coli Bacteremic Urinary Tract Infections

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis